LINC02164

Across TCGA pan-cancer cohorts, LINC02164 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02164 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02164 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02164 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

BLCA, UCEC, and ACC are the cancer types where LINC02164 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.106	0.617	<.001	108	view →
UCEC	DFS	Tertile	All	0.713	0.903	<.001	108	view →
ACC	OS	Tertile	All	0.114	0.892	<.001	72	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	36	view →
HNSC	OS	Tertile	III,IV	0.200	0.679	.002	36	view →
STAD	OS	Tertile	IV	1.000	0.309	.034	33	view →
READ	DFS	Tertile	All	0.111	0.799	.001	18	view →
KIRP	OS	Tertile	III,IV	0.180	0.688	.027	9	view →
BRCA	DFS	Tertile	All	0.405	0.530	.044	6	view →
THCA	OS	Tertile	All	0.342	0.955	.011	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02164–BLCA (DFS)

Open the BLCA breakdown →